CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis
Clinical trial NCT03478111 · COMPLETED
Trial details
- NCT number
- NCT03478111
- Sponsor
- Shanghai Biomabs Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-30
- Primary completion
- 2019-06-23
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.